冠状动脉慢血流现象相关因素分析(2)
第1页 |
参见附件。
[3] Fineschi M,Bravi A,Gori T.The“slow coronary flow”phenomenon:evidence of preserved coronary flow reserve despite increased resting microvascular resistances[J].Int J Cardiol,2008,127:358-361.
[4] Sezgin AT,SigirciA,Barutcu I,et al.Vascular endothelial function in patients with slow coronary flow[J].Coron Artery Dis,2003,14(1):155-161.
[5] Yildiz A,Gur M,Yifulaz R,et al. Association of paraoxonase activity and coronary blood flow[J].Atherosclerosis,2008,197(1):257-263.
[6] Mangieri E,Macchiarelli G,Ciavolella M,et al.Slow coronary flow:clinical and histopathological features in patients with otherwise normal epicardial coronary arteries[J].Cathet Cardiovase Diagn,1996,37(4):375-381.
[7] Gokce M,Kaplan S,Tekelioglu Y,et al.Platelet function disorder in patients with coronary slow flow[J].Clin Cardiol,2005,28(1):145-148.
[8] Sen N,Basar N,Maden O,et al.Increased mean platelet volume in patients with slow coronary flow[J].Platelets,2009,20(1):23-28.
[9] Yilmaz H,Demir I,Uyar Z.Clinical and coronary angiographic characteristics of patients with coronary slow flow[J].Acta Cardiol,2008,63(5):579-584.
[10] Yamashita K,Takahiro K,Kamezaki F,et al.Decreased plasm a extracellular superoxide dismutase level in patient with vasospastic angina[J].Atherosclerosis,2007,191(1):147-152.
[11] 何进舟,仲昕,李晨光,等.冠状动脉慢血流现象的临床分析[J].中国临床医学,2011,6(18):783-784.
[12] 段红艳,王丽霞,王光公,等.冠状动脉慢血流现象的危险因素与临床特征分析[J].实用医学杂志,2010,13(26):2338-2340.
[13] Yeh ET,Anderson HV,Pasceri V,et al.C-reactive protein linking inflammation to cardiovascular complications[J].Circulation,2001,104(9):974-975.
[14] Johnson RJ.Uric acid and diet-insights into the epidemic of cardiovascular disease[J].N Engl J Med,2004,350(10):1071-1073.
(收稿日期:2013-11-11)
您现在查看是摘要介绍页,详见PDF附件。